Cargando…
Cilostazol as an add-on therapy for patients with Alzheimer’s disease in Taiwan: a case control study
BACKGROUND: Combination therapy using acetylcholinesterase inhibitors (AChEIs) and cilostazol is of unknown efficacy for patients with Alzheimer’s disease (AD). METHODS: We explored the therapeutic responses by using a case–control study, which was conducted in Taiwan. We enrolled 30 participants wi...
Autores principales: | Tai, Shu-Yu, Chen, Chun-Hung, Chien, Chen-Yu, Yang, Yuan-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324327/ https://www.ncbi.nlm.nih.gov/pubmed/28231822 http://dx.doi.org/10.1186/s12883-017-0800-y |
Ejemplares similares
-
Cilostazol Add-On Therapy in Patients with Mild Dementia Receiving Donepezil: A Retrospective Study
por: Ihara, Masafumi, et al.
Publicado: (2014) -
Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019) -
Adjunct effect of music therapy on cognition in Alzheimer’s disease in Taiwan: a pilot study
por: Li, Chien-Hsun, et al.
Publicado: (2015) -
End-stage Renal Disease in Taiwan: A Case–Control Study
por: Tsai, Su-Ying, et al.
Publicado: (2009) -
Cilostazol ameliorates diabetic nephropathy by inhibiting high-glucose-induced apoptosis
por: Chian, Chien-Wen, et al.
Publicado: (2020)